USPTO serial 98139758
COAGCARE
Reviewed by CopyMark Law Group
Status 731Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- BICE, DANIEL TRAVIS
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with COAGCARE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,545*
Plus Government fees of $750
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Menlo Park, CA, US
Menlo Park, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Laura Johnson
Laura Johnson FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER LLP901 NEW YORK AVENUE NWWASHINGTON, DC 20001United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medical diagnostic disposables in the nature of medical diagnostic test strips, medical diagnostic test media in the form of cards and cartridges and medical diagnostic reagents for testing blood coagulation, all the foregoing for use in human and veterinary medicine. | ACTIVE | — |
| 009 | Computer hardware for operating medical diagnostic apparatus for measuring blood coagulation; computer hardware for use in connection with blood and blood components processing devices; recorded computer software for operating medical diagnostic apparatus for measuring blood coagulation; downloadable computer software for use in connection with operation of blood processing devices; downloadable computer software for computer software for operating medical diagnostic apparatus for measuring blood coagulation; downloadable mobile application for computer software for operating or viewing results from medical diagnostic apparatus for measuring blood coagulation; all the foregoing for use in human and veterinary medicine; scientific apparatus in the nature of research and medical research laboratory analyzers and diagnostic instruments for research laboratory use for assessing, testing, and examining blood, blood plasma, and blood components; scientific apparatus, namely, vibration-based mechanical measurement apparatus for measuring blood, blood plasma, and blood components, and monitoring the interaction between one or more constituents of blood for research purposes. | ACTIVE | — |
| 010 | Medical diagnostic instruments for analysis of blood, blood plasma, and blood components; Blood testing apparatus; Plasma testing apparatus in the nature of medical diagnostic instrument; Medical apparatus and instruments for blood clotting and coagulation measurements; medical diagnostic equipment, namely, blood coagulation analyzers; portable medical instruments for measuring, testing and analyzing blood, blood plasma, and blood components; medical testing apparatus and diagnostic equipment to measure blood coagulation and to diagnose blood clotting disorders; vibration-based mechanical measurement apparatus for measuring blood, blood plasma, and blood components, and monitoring the interaction between one or more constituents of blood for medical diagnostic purposes; all the foregoing for use in human and veterinary medicine. | ACTIVE | — |
| 042 | Providing online non-downloadable computer software for use in connection with operation of blood processing devices; Providing online non-downloadable computer software for computer software for operating medical diagnostic apparatus for measuring blood coagulation; Providing online non-downloadable computer platform software for operating medical diagnostic apparatus for measuring blood coagulation; all the foregoing for use in human and veterinary medicine. | ACTIVE | — |
| 044 | Medical services, namely, providing blood coagulation testing to patients for medical diagnostic purposes; medical diagnostic testing, monitoring and reporting services; Medical testing for diagnostic or treatment purposes; medical assistance services, namely, blood coagulation management and monitoring for medical diagnosis and treatment purposes; all the foregoing for use in human and veterinary medicine | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Abram Scientific, Inc.
- Other trademarks owned by Abram Scientific, Inc.
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named COAGCARE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 5, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 4, 2026 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Sep 4, 2026 | EXT2 | SOU EXTENSION 2 FILED | — |
| Sep 4, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 12, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 11, 2026 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Mar 11, 2026 | EXT1 | SOU EXTENSION 1 FILED | — |
| Mar 11, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 16, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 22, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 22, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 16, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 16, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 15, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 15, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 15, 2025 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Feb 13, 2025 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Feb 13, 2025 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Nov 15, 2024 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Nov 15, 2024 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 15, 2024 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 18, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 18, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 18, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 16, 2024 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Jul 16, 2024 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Apr 19, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 19, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 19, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 18, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 18, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 22, 2023 | NWAP | NEW APPLICATION ENTERED | — |